1. Home
  2. NRSN vs CISO Comparison

NRSN vs CISO Comparison

Compare NRSN & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • CISO
  • Stock Information
  • Founded
  • NRSN 2017
  • CISO 2015
  • Country
  • NRSN Israel
  • CISO United States
  • Employees
  • NRSN N/A
  • CISO N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • CISO Computer Software: Prepackaged Software
  • Sector
  • NRSN Health Care
  • CISO Technology
  • Exchange
  • NRSN Nasdaq
  • CISO Nasdaq
  • Market Cap
  • NRSN 31.1M
  • CISO 31.4M
  • IPO Year
  • NRSN 2021
  • CISO N/A
  • Fundamental
  • Price
  • NRSN $1.22
  • CISO $1.16
  • Analyst Decision
  • NRSN Buy
  • CISO
  • Analyst Count
  • NRSN 2
  • CISO 0
  • Target Price
  • NRSN $14.00
  • CISO N/A
  • AVG Volume (30 Days)
  • NRSN 404.8K
  • CISO 960.9K
  • Earning Date
  • NRSN 09-17-2025
  • CISO 11-17-2025
  • Dividend Yield
  • NRSN N/A
  • CISO N/A
  • EPS Growth
  • NRSN N/A
  • CISO N/A
  • EPS
  • NRSN N/A
  • CISO N/A
  • Revenue
  • NRSN N/A
  • CISO $28,792,765.00
  • Revenue This Year
  • NRSN N/A
  • CISO N/A
  • Revenue Next Year
  • NRSN N/A
  • CISO N/A
  • P/E Ratio
  • NRSN N/A
  • CISO N/A
  • Revenue Growth
  • NRSN N/A
  • CISO N/A
  • 52 Week Low
  • NRSN $0.80
  • CISO $0.30
  • 52 Week High
  • NRSN $2.60
  • CISO $3.84
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 44.56
  • CISO 55.59
  • Support Level
  • NRSN $1.12
  • CISO $1.06
  • Resistance Level
  • NRSN $1.26
  • CISO $1.22
  • Average True Range (ATR)
  • NRSN 0.06
  • CISO 0.12
  • MACD
  • NRSN 0.01
  • CISO -0.00
  • Stochastic Oscillator
  • NRSN 36.87
  • CISO 65.38

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

Share on Social Networks: